Bruker Corporation is a healthcare company.
Bruker Corporation (BRKR) is expected to report earnings on Monday, November 2, 2026, after the close. Estimated release time 07:00 ET. Consensus EPS estimate is $0.42.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $0.38 | $0.49 | +27.3% | $838.50M |
| 2026-05-07 | FY2026 Q1 | $0.23 | $0.31 | +34.8% | $823.40M |
| 2026-02-27 | FY2025 Q4 | — | $0.10 | — | $977.20M |
| 2025-11-05 | FY2025 Q3 | $0.33 | $0.60 | +81.8% | $860.50M |
| 2025-08-06 | FY2025 Q2 | $0.33 | $0.32 | -3.0% | $797.40M |
| 2025-05-07 | FY2025 Q1 | $0.46 | $0.47 | +2.2% | $801.40M |
| 2025-03-03 | FY2024 Q4 | — | $0.09 | — | $979.60M |
| 2024-11-05 | FY2024 Q3 | $0.61 | $0.27 | -55.7% | $864.40M |
BRKR has beaten consensus EPS in 4 of its last 8 reported quarters.
BRKR reported Aug 5. The highlights: EPS of $0.49 — a big beat vs the $0.38 estimate (+27%); revenue of $838M — in line with the $854M consensus. Focus now shifts to academic funding impact and biopharma.
BRKR pays a quarterly dividend, currently yielding 0.34%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-09-21 | $0.05 | 2026-10-07 |
| 2026-06-22 | $0.05 | 2026-07-07 |
| 2026-03-23 | $0.05 | 2026-04-07 |
| 2025-12-08 | $0.05 | 2026-01-02 |
| 2025-09-23 | $0.05 | 2025-10-03 |
| 2025-06-16 | $0.05 | 2025-06-27 |